Funding available for life science companies

Innovative firms could net up to €7 million from a new fund partnership, writes Dermot Corrigan

21st February, 2009

Seroba Kernel Life Sciences, the newly formed venture capital fund partnership, will plough investment funds of up to €7 million into as many as 15 companies in Britain and Ireland.

It will fund the investment from an initial pot of €75 million, targeting product-focused and innovative life science companies at early to mid-stage development. Seroba Kernel was one of four investors which last week announced a major €18 million investment in Dublin-based biotech Opsona Therapeutics.


Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Newsround: What Thursday’s papers say